Tissue inhibitors of metalloproteinase expression in human breast cancer: TIMP-3 is associated with adjuvant endocrine therapy success by Span, Paul N, Lindberg, Raija LP, Manders, Peggy, Tjan-Heijnen, Vivianne CG, Heuvel, Joop JTM, Beex, Louk VAM, Sweep, CGJ (Fred)

Get full text

External quality assessment of trans-European multicentre antigen determinations (enzyme-linked immunosorbent assay) of urokinase-type plasminogen activator (uPA) and its type 1 in... by Sweep, CGJ, Geurts-Moespot, J, Grebenschikov, N, de Witte, JH, Heuvel, JJTM, Schmitt, M, Duffy, MJ, Jänicke, F, Kramer, MD, Foekens, JA, Brünner, N, Brugal, G, Pedersen, AN, Benraad, ThJ

Get full text

Expression and localisation of the new metalloproteinase inhibitor RECK (reversion inducing cysteine-rich protein with Kazal motifs) in inflamed synovial membranes of patients with... by van Lent, P L E M, Span, P N, Sloetjes, A W, Radstake, T R D J, van Lieshout, A W T, Heuvel, J J T M, Sweep, C G J, van den Berg, W B

Get full text

Harmonisation of multi-centre real-time reverse-transcribed PCR results of a candidate prognostic marker in breast cancer: An EU-FP6 supported study of members of the EORTC – Patho... by Span, P.N, Sieuwerts, A.M, Heuvel, J.J.T.M, Spyratos, F, Duffy, M.J, Eppenberger-Castori, S, Vacher, S, O’Brien, K, McKiernan, E, Pierce, A, Vuaroqueaux, V, Foekens, J.A, Sweep, F.C.G.J, Martens, J.W.M

Get full text

Molecular beacon reverse transcription-PCR of human chorionic gonadotropin-beta-3, -5, and -8 mRNAs has prognostic value in breast cancer by Span, Paul N, Manders, Peggy, Heuvel, Joop J T M, Thomas, Chris M G, Bosch, Remko R, Beex, Louk V A M, Sweep, C G J Fred

Get full text

Prognostic impact of urokinase-type plasminogen activator receptor (uPAR) in cytosols and pellet extracts derived from primary breast tumours by Witte, J H de, Foekens, J A, Brünner, N, Heuvel, J J T M, Tienoven, ThH van, Look, M P, Klijn, J G M, Geurts-Moespot, A, Grebenchtchikov, N, Benraad, ThJ, Sweep, C G J

Get full text

Prognostic value of tissue-type plasminogen activator (tPA) and its complex with the type-1 inhibitor (PAI-1) in breast cancer by Witte, J H de, Sweep, C G J, Klijn, J G M, Grebenschikov, N, Peters, H A, Look, M P, Tienoven, ThH van, Heuvel, J J T M, Vries, J Bolt-De, Benraad, ThJ, Foekens, J A

Get full text

Immunoassays (ELISA) of urokinase-type plasminogen activator (uPA): Report of an EORTC/BIOMED-1 Workshop by Benraad, Th.J., Geurts-moespot, J., Grøndahl-hansen, J., Schmitt, M., Heuvel, J.J.T.M., de Witte, J.H., Foekens, J.A., Leake, R.E., Brünner, N., Sweep, C.G.J.

Get full text

E1AF expression levels are not associated with prognosis in human breast cancer by SPANS, Paul N, MANDERS, Peggy, HEUVEL, Joop J. T. M, BEEX, Louk V. A. M, SWEEPS, C. G. J

Get full text

Prognostic impact of urokinase-type plasminogen activator (uPA) and its inhibitor (PAI-1) in cytosols and pellet extracts derived from 892 breast cancer patients by de Witte, J H, Sweep, C G J, Klijn, J G M, Grebenschikov, N, Peters, H A, Look, M P, van Tienoven, Th H, Heuvel, J J T M, van Putten, W L J, Benraad, Th J, Foekens, J A

Get full text

Epidermal growth factor receptor-negative tumors are predominantly confined to the subgroup of estradiol receptor-positive human primary breast cancers by KOENDERS, P. G, BEEX, L. V. A. M, GEURTS-MOESPOT, A, HEUVEL, J. J. T. M, KIENHUIS, C. B. M, BENRAAD, T. J

Get full text